Analyst Upgrades and Options Caution Collide at Valero

VLO has rallied 16% in a month to $397, but a surge in defensive options positioning this week suggests not everyone believes the run has legs.

The options market is the sharpest signal right now. The put/call ratio jumped to 1.34 on Tuesday — more than 2.5 standard deviations above its 20-day average of 1.13. That makes this week's reading one of the most defensively skewed of the past year, with the 52-week high at 1.78 and the low at 0.61. Investors are paying more for downside protection even as the stock posts fresh highs — a divergence worth watching closely.

Short interest, by contrast, tells a far less charged story. Bears hold just 3.3% of the free float short, a level that has edged up roughly 1.3% on the week but remains down nearly 8% from a month ago. The borrow market is exceptionally loose — availability is running at around 2,789%, meaning there are more than 27 shares available to lend for every one already borrowed. Cost to borrow is a negligible 0.47%, easing about 10% on the week despite a 62% rise over the past month. There is no meaningful squeeze pressure in the lending market, and no structural reason for shorts to panic at these levels.

The analyst community, on the other hand, has moved with striking conviction. Raymond James lifted its target from $350 to $450 just this week while keeping a Strong Buy. Morgan Stanley also raised its target — from $255 to $411 — maintaining Equal-Weight. UBS moved its Buy-rated target to $450 last week, up from $355. Piper Sandler pushed to $435 from $329. Five firms raised targets in September alone. The consensus rating still shows a stray Sell, but the direction of travel from the active revisions is unambiguously bullish, with most targets now sitting above the current price. The mean price target of $355 looks stale against these fresh revisions and should be treated with caution; the more recent individual targets cluster in the $410–$450 range.

The bull case rests on Valero's Gulf Coast refining footprint, low-cost positioning within the US refining peer group, and a cash return program that analysts estimate will deliver a total return-on-capital yield around 15% averaged across 2026-27. The bear case is less about company fundamentals and more about macro: weak refining margins, crude oversupply weighing on spreads, and limited IMO regulatory tailwinds. The dividend score ranks in the 86th percentile across the ORTEX universe, a reminder that income-oriented holders provide a stable floor. The PE multiple is running at roughly 9.8x, with EV/EBITDA near 6.7x — undemanding for a refiner at the top of its cycle.

Peers broadly moved in sympathy this week. MPC added 3.3% on the week and PSX gained 2.2%, while PBF dipped 2.7% — a hint that not all refiners are drawing equal enthusiasm. CVI outpaced the group with a 13% weekly gain, suggesting some rotation toward smaller, higher-beta refiners may be underway.

Insider activity does not add urgency. The most notable recent trade was an SVP selling $2 million in stock in late June at prices well below the current level — executed outside any 10b5-1 plan, though at significance scores that suggest routine rather than alarming conviction. Net insider selling over the past 90 days is modest at roughly 15,000 shares.

Q3 earnings are scheduled for October 22. The last print on July 30 sent the stock up 3.8% the next day, with a muted five-day follow-through of around 0.6%. The question heading into that date is whether the margin environment has improved enough to justify targets that are now meaningfully above where many analysts sat just six weeks ago — and whether the elevated put/call ratio reflects genuine hedging ahead of results or something more cautious about the sustainability of the current price level.